Literature DB >> 25049276

Caution over use of ES2 as a model of ovarian clear cell carcinoma.

Angie L M Kwok1, Oscar Gee-Wan Wong1, Esther S Y Wong1, Obe Ka-Lai Tsun1, Ka-Kui Chan1, Annie Nga-Yin Cheung1.   

Abstract

Entities:  

Keywords:  CANCER; CANCER RESEARCH; GYNAECOLOGICAL PATHOLOGY

Mesh：

Substances：

Year:  2014        PMID： 25049276     DOI： 10.1136/jclinpath-2014-202430

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  7 in total

1.  The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer.

Authors:  Dhwani Haria; Bon Quy Trinh; Song Yi Ko; Nicolas Barengo; Jinsong Liu; Honami Naora
Journal:  Am J Pathol       Date:  2015-06-09       Impact factor: 4.307

2.  Caveolin-1-ACE2 axis modulates xenobiotic metabolism-linked chemoresistance in ovarian clear cell carcinoma.

Authors:  Arulkumar Nagappan; Ki-Hyung Kim; Yuseok Moon
Journal:  Cell Biol Toxicol       Date:  2022-05-27       Impact factor: 6.819

3.  CRISPR/Cas9 Screening for Identification of Genes Required for the Growth of Ovarian Clear Cell Carcinoma Cells.

Authors:  Ayako Kawabata; Tomoatsu Hayashi; Yoko Akasu-Nagayoshi; Ai Yamada; Naomi Shimizu; Naoko Yokota; Ryuichiro Nakato; Katsuhiko Shirahige; Aikou Okamoto; Tetsu Akiyama
Journal:  Curr Issues Mol Biol       Date:  2022-04-07       Impact factor: 2.976

4.  The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.

Authors:  Artur A Serebrenik; Prokopios P Argyris; Matthew C Jarvis; William L Brown; Martina Bazzaro; Rachel I Vogel; Britt K Erickson; Sun-Hee Lee; Krista M Goergen; Matthew J Maurer; Ethan P Heinzen; Ann L Oberg; Yajue Huang; Xiaonan Hou; S John Weroha; Scott H Kaufmann; Reuben S Harris
Journal:  Clin Cancer Res       Date:  2020-02-14       Impact factor: 12.531

5.  GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.

Authors:  Mingo Ming-Ho Yung; Hermit Wai-Man Tang; Patty Chun-Hui Cai; Thomas Ho-Yin Leung; Siew-Fei Ngu; Karen Kar-Loen Chan; Dakang Xu; Huijuan Yang; Hextan Yuen-Sheung Ngan; David Wai Chan
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

6.  NEXGB: A Network Embedding Framework for Anticancer Drug Combination Prediction.

Authors:  Fanjie Meng; Feng Li; Jin-Xing Liu; Junliang Shang; Xikui Liu; Yan Li
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

7.  Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.

Authors:  Rain R Chen; Mingo M H Yung; Yang Xuan; Shijie Zhan; Leanne L Leung; Rachel R Liang; Thomas H Y Leung; Huijuan Yang; Dakang Xu; Rakesh Sharma; Karen K L Chan; Siew-Fei Ngu; Hextan Y S Ngan; David W Chan
Journal:  Commun Biol       Date:  2019-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.